Also, neoantigen DNA vaccination together with anti-PD-1 antibody mediated the colon cancer regression in a CD8+ T cell-dependent manner, as opposed to anti-PD-1 antibody alone that failed in tumor elimination [113]. The gene discussed is PDCD1; the disease is malignant colon neoplasm.